GSK plc (GSK) Stock Forecast
Data as of Sep 20, 2026Healthcare · Current price $50.13 (-1.81%)
Consensus Target
$52.45
Upside
+19.7%
Analysts
1
Rating
Sell(4.00)
Price Target Range
Low $35.25Consensus $52.45High $85.00
▲ Current $50.13
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
6-Month Trend
No rating trend data.
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
No analyst price targets available.
GSK vs Sector & Market
| Metric | GSK | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 4.00 | 2.25 | 2.42 |
| Analyst Count | 1 | 8 | 18 |
| Target Upside | +19.7% | +22243.7% | +21.5% |
| P/E Ratio | 14.26 | 3.75 | 38.34 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $11.44B | $12.04B | $12.40B | 2 |
| 2026-12-31 | $11.45B | $12.06B | $12.42B | 2 |
| 2027-03-31 | $10.32B | $10.87B | $11.20B | 2 |
| 2027-06-30 | $11.07B | $11.66B | $12.00B | 2 |
| 2027-09-30 | $11.85B | $12.48B | $12.85B | 2 |
| 2027-12-31 | $11.86B | $12.49B | $12.87B | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $1.36 | $1.46 | $1.52 | 1 |
| 2026-12-31 | $0.76 | $0.81 | $0.85 | 1 |
| 2027-03-31 | $1.23 | $1.31 | $1.36 | 1 |
| 2027-06-30 | $1.32 | $1.41 | $1.47 | 1 |
| 2027-09-30 | $1.53 | $1.64 | $1.71 | 1 |
| 2027-12-31 | $0.77 | $0.82 | $0.86 | 1 |
Frequently Asked Questions
What is the analyst consensus for GSK?
The consensus among 1 analysts covering GSK plc (GSK) is Sell with an average price target of $52.45.
What is the highest price target for GSK?
The highest analyst price target for GSK is $85.00.
What is the lowest price target for GSK?
The lowest analyst price target for GSK is $35.25.
How many analysts cover GSK?
1 analysts have issued ratings for GSK plc in the past 12 months.
Is GSK a buy or sell right now?
Based on 1 analyst ratings, GSK has a consensus rating of Sell (4.00/5) with a +19.7% upside to the consensus target of $52.45.
What are the earnings estimates for GSK?
Analysts estimate GSK will report EPS of $1.46 for the period ending 2026-09-30, with revenue estimated at $12.04B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.